PURPOSE: This investigation sought to optimize ultrasmall particles of iron oxide (USPIO) contrast agent dosage for visualizing cerebral microvasculature on an 8.0-Tesla ultra high field magnetic resonance imaging system. MATERIALS AND METHODS: USPIO contrast agent was intravenously administered to 3 groups of 4 rats at 1, 2, and 3 mg Fe/kg. Each animal was scanned before and after injection of USPIO using a high resolution T2*-weighted gradient recalled echo sequence with an in-plane resolution of 78 microm. The signal-to-noise ratio (SNR) and the number of microvessels visualized within the cortex and basal ganglia were calculated and compared before and after the administration of USPIO. RESULTS: As the USPIO dose increased, microvascular conspicuity increased, and SNR decreased. A dosage of 2 mg Fe/kg improved microvascular visualization in both cortex and basal ganglion regions relative to 1 mg Fe/kg without significantly sacrificing SNR as was the case at 3 mg Fe/kg. CONCLUSION: Two mg Fe/kg USPIO is an optimal dose when imaging normal rat cerebral microvasculature using GRE T2*-weighted MR imaging at a field strength of 8 T.
PURPOSE: This investigation sought to optimize ultrasmall particles of iron oxide (USPIO) contrast agent dosage for visualizing cerebral microvasculature on an 8.0-Tesla ultra high field magnetic resonance imaging system. MATERIALS AND METHODS: USPIO contrast agent was intravenously administered to 3 groups of 4 rats at 1, 2, and 3 mg Fe/kg. Each animal was scanned before and after injection of USPIO using a high resolution T2*-weighted gradient recalled echo sequence with an in-plane resolution of 78 microm. The signal-to-noise ratio (SNR) and the number of microvessels visualized within the cortex and basal ganglia were calculated and compared before and after the administration of USPIO. RESULTS: As the USPIO dose increased, microvascular conspicuity increased, and SNR decreased. A dosage of 2 mg Fe/kg improved microvascular visualization in both cortex and basal ganglion regions relative to 1 mg Fe/kg without significantly sacrificing SNR as was the case at 3 mg Fe/kg. CONCLUSION: Two mg Fe/kg USPIO is an optimal dose when imaging normal rat cerebral microvasculature using GRE T2*-weighted MR imaging at a field strength of 8 T.
Authors: G A Christoforidis; E C Bourekas; M Baujan; A M Abduljalil; A Kangarlu; D G Spigos; D W Chakeres; P M Robitaille Journal: J Comput Assist Tomogr Date: 1999 Nov-Dec Impact factor: 1.826
Authors: Gregory A Christoforidis; John C Grecula; Herbert B Newton; Allahyar Kangarlu; Amir M Abduljalil; Petra Schmalbrock; Donald W Chakeres Journal: AJNR Am J Neuroradiol Date: 2002-10 Impact factor: 3.825
Authors: Achim H Kaim; Thorsten Wischer; Terence O'Reilly; Gernot Jundt; Johannes Fröhlich; Gustav K von Schulthess; Peter R Allegrini Journal: Radiology Date: 2002-12 Impact factor: 11.105
Authors: Edit Dósa; Suchita Tuladhar; Leslie L Muldoon; Bronwyn E Hamilton; William D Rooney; Edward A Neuwelt Journal: Stroke Date: 2011-04-14 Impact factor: 7.914
Authors: Andrew W Gorman; Kofi M Deh; Caspar M Schwiedrzik; Julie R White; Ernest Victor Groman; Clark A Fisher; Kelly M Gillen; Pascal Spincemaille; Skye Rasmussen; Martin R Prince; Henning U Voss; Winrich A Freiwald; Yi Wang Journal: Comp Med Date: 2018-04-02 Impact factor: 0.982
Authors: Gregory A Christoforidis; Ming Yang; Marinos S Kontzialis; Douglas G Larson; Amir Abduljalil; Michelle Basso; Weilian Yang; Abhik Ray-Chaudhury; Johannes Heverhagen; Michael V Knopp; Rolf F Barth Journal: Invest Radiol Date: 2009-07 Impact factor: 6.016
Authors: Asamoah Bosomtwi; Quan Jiang; Guang L Ding; Li Zhang; Zheng G Zhang; Mei Lu; James R Ewing; Michael Chopp Journal: J Cereb Blood Flow Metab Date: 2008-09-03 Impact factor: 6.200